Search hospitals > California > Roseville
Kaiser Permanente-Roseville
Claim this profileRoseville, California 95661
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
225 reported clinical trials
9 medical researchers
Summary
Kaiser Permanente-Roseville is a medical facility located in Roseville, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Kaiser Permanente-Roseville is involved with conducting 225 clinical trials across 352 conditions. There are 9 research doctors associated with this hospital, such as Aarati Rao, Jennifer M. Suga, Samantha A. Seaward, and Tatjana Kolevska, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Aarati RaoKaiser Permanente-Oakland4 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
56 reported clinical trials
109 drugs studied
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
34 reported clinical trials
98 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara2 years of reported clinical research
Studies Cancer
Studies Breast Cancer
22 reported clinical trials
63 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo7 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
21 reported clinical trials
51 drugs studied
Clinical Trials running at Kaiser Permanente-Roseville
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Cutaneous Melanoma
Squamous Cell Carcinoma
Melanoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser Permanente-Roseville?
Kaiser Permanente-Roseville is a medical facility located in Roseville, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Kaiser Permanente-Roseville is involved with conducting 225 clinical trials across 352 conditions. There are 9 research doctors associated with this hospital, such as Aarati Rao, Jennifer M. Suga, Samantha A. Seaward, and Tatjana Kolevska, MD.